Growth Hormone Release
CJC-1295 is a long-acting GHRH analog that produces sustained growth hormone release. Often paired with Ipamorelin for synergistic effects.
Select Your Plan
First month only
$239 — 1-month supply. Includes medication, consultation, physician review, and direct shipping. First-time patients only. No cancellation penalty.
First-time buyer verification — your name is matched against our prescription records to confirm new patient eligibility.
Typical Dosing Protocol
Typical dose: 100–300mcg 2–3x per week via subcutaneous injection. Often stacked with Ipamorelin. Cycle: 8–12 weeks.
✧✦ Want a protocol built around your biology?
Add Precision — lab testing + provider-guided optimization.
Patients often combine CJC-1295 with these protocols for enhanced results.
Your cart is empty.
Start your protocol →